🚨Arizona Corrections Department Seeks Import of Controlled Substances
Arizona Department of Corrections has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More⚖️Revocation of DEA Registration for William Thompson IV, M.D.
The Drug Enforcement Administration (DEA) has issued a revocation order for the DEA registration of William Thompson IV, M.D., citing lack of authority to handle controlled substances due to the revocation of his California medical license. The order underscores the importance of maintaining state licensing for medical practitioners engaged in dispensing controlled substances.
Learn More💊American Radiolabeled Chem's Controlled Substances Manufacturing Application
American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊AJNA Biosciences Seeks Registration as Bulk Manufacturer of Controlled Substances
AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊DEA Notice
Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More⚖️Veranova, L.P. DEA Import Application for Controlled Substances
Veranova, L.P. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊DEA Notice on AndersonBrecon's Controlled Substance Import Application
AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More⚖️DEA Revocation of Registration for James F. Brown, D.P.M.
The Department of Justice's Drug Enforcement Administration issued a Decision and Order revoking James F. Brown’s DEA registration due to material falsification on his application and lack of authority in California. The case highlights the critical importance of accurate disclosures in licensing and compliance within the healthcare sector.
Learn More💊New Regulations for Fentanyl-Related Substances Impacting Businesses
The Drug Enforcement Administration proposes placing three fentanyl-related substances, as identified in this proposed rule, in schedule I of the Controlled Substances Act. These three substances fall within the definition of fentanyl-related substances set forth in the February 6, 2018 temporary scheduling order. Through the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act, which became law on February 6, 2020, Congress extended the temporary control of fentanyl-related substances until May 6, 2021. This temporary order was subsequently extended multiple times, most recently on March 15, 2025, which extended the order until September 30, 2025. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle these three specific controlled substances.
Learn More⚖️Proposed Schedule I Classification for 3-Methoxyphencyclidine
The Drug Enforcement Administration proposes placing 3- methoxyphencyclidine, including its salts, isomers, and salts of isomers, an arylcyclohexylamine hallucinogen, in schedule I of the Controlled Substances Act. This action is proposed to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle 3-methoxyphencyclidine.
Learn More